Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Miyazaki

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
International Journal of Hematology|April 16, 2023
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndromeHiroyoshi Kunimoto, Ayaka Miura, Ayaka Maeda, et al.
Asia-Pacific Journal of Clinical Oncology|July 10, 2018
Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) studyYoshimi Ishii, Shin Fujisawa, Taiki Ando, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|August 30, 2019
Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational StudyAyako Matsumura, Takuya Miyazaki, Takayoshi Tachibana, et al.
Hematology (Amsterdam, Netherlands)|November 4, 2024
Impact of bone marrow nucleated cell subfractions on transplant outcomes in patients with acute lymphoblastic leukemiaJun Nukui, Takayoshi Tachibana, Takuya Miyazaki, et al.
Leukemia Research|May 4, 2012
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemiaTakuya Miyazaki, Hiroyuki Fujita, Katsumichi Fujimaki, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2025
Factors Predicting Spontaneous Regression in Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative DiseasesKosuke Takayama, Yuki Nakajima, Takuya Miyazaki, et al.
Hematology (Amsterdam, Netherlands)|May 27, 2022
Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantationHaruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 25, 2011
[ABVD chemotherapy for Hodgkin lymphoma at a single institute]Rika Ohshima, Shigeki Motomura, Chizuko Hashimoto, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 12, 2021
Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective StudyHiroyuki Takahashi, Rika Sakai, Takayuki Sakuma, et al.
International Journal of Hematology|December 11, 2023
Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell transplantationJun Nukui, Takayoshi Tachibana, Takuya Miyazaki, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Hematology|April 16, 2023
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndromeHiroyoshi Kunimoto, Ayaka Miura, Ayaka Maeda, et al.
Asia-Pacific Journal of Clinical Oncology|July 10, 2018
Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) studyYoshimi Ishii, Shin Fujisawa, Taiki Ando, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|August 30, 2019
Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational StudyAyako Matsumura, Takuya Miyazaki, Takayoshi Tachibana, et al.
Hematology (Amsterdam, Netherlands)|November 4, 2024
Impact of bone marrow nucleated cell subfractions on transplant outcomes in patients with acute lymphoblastic leukemiaJun Nukui, Takayoshi Tachibana, Takuya Miyazaki, et al.
Leukemia Research|May 4, 2012
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemiaTakuya Miyazaki, Hiroyuki Fujita, Katsumichi Fujimaki, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2025
Factors Predicting Spontaneous Regression in Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative DiseasesKosuke Takayama, Yuki Nakajima, Takuya Miyazaki, et al.
Hematology (Amsterdam, Netherlands)|May 27, 2022
Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantationHaruka Teshigawara-Tanabe, Maki Hagihara, Jun Aoki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 25, 2011
[ABVD chemotherapy for Hodgkin lymphoma at a single institute]Rika Ohshima, Shigeki Motomura, Chizuko Hashimoto, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 12, 2021
Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective StudyHiroyuki Takahashi, Rika Sakai, Takayuki Sakuma, et al.
International Journal of Hematology|December 11, 2023
Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell transplantationJun Nukui, Takayoshi Tachibana, Takuya Miyazaki, et al.
Pageof 11